Health Legislation

This Decree approves the amended statutes of the Beninese pharmaceutical regulatory agency, now named “Beninese Agency for Medicines and other Health Products”.

This Law determines the use of the human body, organs, tissues, cells and products of the human body for therapeutic, educational or scientific purposes.

The executive Decree No 22-401 of 26 Rabie Ethani 1444 establishes the composition, organization and operation of the National Health Observatory. It was published in the Official Journal of 24 November 2022 (pages 7 -10).

The law defines the legal framework for the prevention and comprehensive care of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS). The law includes the rights and obligations of people living with HIV as well as the prevention and prohibition of discriminatory practices. The law includes as well the treatments in the health system in Cabo Verde among other issues.

This law defines the general regime for the prevention and control of smoking, establishing rules regarding the protection from exposure; the advertising; the prohibition of the promotion and sponsorship of recreational and cultural activities, and the labelling among other issues. 

This Decree regulates the organization and operation of a public establishment called the National Institute of Public Health. This document is published as a part of the Official Journal and the Decree is located on page 31 of the file.

The purpose of this Law is to establish mechanisms for the protection and promotion of health, the prevention and control of diseases, as well as threats and risks to public health.

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

This Decree establishes and fixes the rules of organization and operation of the Senegalese Pharmaceutical Regulatory Agency (ARP)

This decree determines the conditions for the creation, approval, operation and control of reproductive health structures in application of the provisions of Article 12 paragraph 3 of Law No. 2003-04 of March 3, 2003 relating to the sexual and reproductive health.

This Law provides amendments to the provisions of Articles 17, 17-1, 17-2, 17-3, 17-4, 17-5, 17-6, 17-7, 19-1 of the Law No 2003-04 of 03 March 2003 relating to sexual health and reproduction.

The law creates the Burundian Authority for the Regulation of Medicines for Human Use and Food. The authority's general aim is to protect public health by promoting the quality and safety of products such as prefabricated and ambient foods, medicines for human use, cosmetics and dietary products containing active ingredients, herbal medicines, traditional medicines, and medical devices, among others.

The decree regulates the establishment, organization and functioning of the National Public Health Institute of Burundi.

This document provides National Guidelines on Task Delegation in Reproductive Health Family Planning Nutrition Noncommunicable Diseases.

The Decree approves the Organic Statute of the Autoridade Nacional Reguladora de Medicamento (The National Medicines Regulatory Authority). The purpose of this Decree is to define the rules governing the organization, management and operation, as well as the powers of its bodies.

The Decree establishes free access to family planning care and services in Burkina Faso (art.1). These are provided in public health facilities by community health workers (art.2). Private facilities can choose to implement the same, but need to sign an agreement with the Ministry of Health to settle the conditions and modalities (art.3). Specific services covered are to be determined by a joint order from the Ministers responsible for Health and Finances (art.4). These measures are financed by the budget of the State and partners (art. 5) and will be realized progressively (art. 6).

This law relates to the fight against tobacco; it applies to tobacco growing, regulation of the manufacture, packaging, labelling, marketing and importing of tobacco and tobacco products, as well as advertising.

This Act establishes the Pharmacy and Medicines Regulatory Authority; provides for the functions and powers of the Authority; and provides for matters connected therewith and incidental thereto.

The Ordinance creates a national public scientific and technological establishment called the "Institut national de Santé Publique" (National Institute of Public Health). The mission of the Institut National de Santé Publique is to set up a health monitoring and epidemiological surveillance system, and to promote research into health policies and systems.

The Decree rules on the organization and operating procedures of the National Institute of Public Health created by Ordinance n°2019-011/P-RM of March 27, 2019 creating the National Institute of Public Health.